Literature DB >> 23732296

Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.

Anshul A Pandya1, Jerrel L Yakel.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are ligand-gated cation-conducting transmembrane channels from the cys-loop receptor superfamily. The neuronal subtypes of these receptors (e.g. the α7 and α4β2 subtypes) are involved in neurobehavioral processes such as anxiety, the central processing of pain, food intake, nicotine seeking behavior, and a number of cognitive functions like learning and memory. Neuronal nAChR dysfunction is involved in the pathophysiology of many neurological disorders, and behavioral studies in animals are useful models to assess the effects of compounds that act on these receptors. Allosteric modulators are ligands that bind to the receptors at sites other than the orthosteric site where acetylcholine, the endogenous agonist for the nAChRs, binds. While conventional ligands for the neuronal nAChRs have been studied for their behavioral effects in animals, allosteric modulators for these receptors have only recently gained attention, and research on their behavioral effects is growing rapidly. Here we will discuss the behavioral effects of allosteric modulators of the neuronal nAChRs. Published by Elsevier Inc.

Entities:  

Keywords:  ACh; Allosteric modulation; NAM; PAM; acetylcholine; animal behavioral studies; cognition; nAChRs; negative allosteric modulator; neuronal nicotinic acetylcholine receptors; nicotinic acetylcholine receptor; pain; positive allosteric modulator; positive allosteric modulators

Mesh:

Substances:

Year:  2013        PMID: 23732296      PMCID: PMC3797251          DOI: 10.1016/j.bcp.2013.05.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  120 in total

1.  Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats.

Authors:  Ryan F Yoshimura; Derk J Hogenkamp; Wen Y Li; Minhtam B Tran; James D Belluzzi; Edward R Whittemore; Frances M Leslie; Kelvin W Gee
Journal:  J Pharmacol Exp Ther       Date:  2007-09-14       Impact factor: 4.030

2.  Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide).

Authors:  John Dunlop; Tim Lock; Brian Jow; Fabrizio Sitzia; Steven Grauer; Flora Jow; Angela Kramer; Mark R Bowlby; Andrew Randall; Dianne Kowal; Adam Gilbert; Thomas A Comery; James Larocque; Veronica Soloveva; Jon Brown; Renza Roncarati
Journal:  J Pharmacol Exp Ther       Date:  2008-12-02       Impact factor: 4.030

3.  Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.

Authors:  Gareth T Young; Ruud Zwart; Alison S Walker; Emanuele Sher; Neil S Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-12       Impact factor: 11.205

4.  A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.

Authors:  Qiang Liu; Yao Huang; Fenqin Xue; Alain Simard; Jamie DeChon; Guohui Li; Jianliang Zhang; Linda Lucero; Min Wang; Michael Sierks; Gang Hu; Yongchang Chang; Ronald J Lukas; Jie Wu
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

5.  Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.

Authors:  Tse-Yu Wu; Caleb M Smith; Steven M Sine; Mark M Levandoski
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

6.  Attenuation of pharmacologically-induced attentional impairment by methylphenidate in rats.

Authors:  Amir H Rezvani; Ehsan Kholdebarin; Marty C Cauley; Elizabeth Dawson; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2008-11-17       Impact factor: 3.533

7.  Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice.

Authors:  Marjolein A van Maanen; Maria C Lebre; Tom van der Poll; Gregory J LaRosa; Daniel Elbaum; Margriet J Vervoordeldonk; Paul P Tak
Journal:  Arthritis Rheum       Date:  2009-01

Review 8.  Desensitization of nicotinic acetylcholine receptors as a strategy for drug development.

Authors:  Jerry J Buccafusco; J Warren Beach; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2008-11-20       Impact factor: 4.030

9.  Nicotinic receptors, allosteric proteins and medicine.

Authors:  Jean-Pierre Changeux; Antoine Taly
Journal:  Trends Mol Med       Date:  2008-02-11       Impact factor: 11.951

10.  Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.

Authors:  Tamaki Hayase
Journal:  BMC Neurosci       Date:  2007-09-18       Impact factor: 3.288

View more
  24 in total

Review 1.  Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.

Authors:  Jingyi Wang; Jon Lindstrom
Journal:  Br J Pharmacol       Date:  2017-03-20       Impact factor: 8.739

2.  Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt.

Authors:  Robert Ross MacLean; Andrew J Waters; Emily Brede; Mehmet Sofuoglu
Journal:  Hum Psychopharmacol       Date:  2018-06-21       Impact factor: 1.672

Review 3.  Nicotinic ACh receptors as therapeutic targets in CNS disorders.

Authors:  Kelly T Dineley; Anshul A Pandya; Jerrel L Yakel
Journal:  Trends Pharmacol Sci       Date:  2015-01-29       Impact factor: 14.819

4.  Multiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.

Authors:  Yann S Mineur; Gianna M Fote; Sam Blakeman; Emma L M Cahuzac; Sylvia A Newbold; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

5.  ELIC-α7 Nicotinic acetylcholine receptor (α7nAChR) chimeras reveal a prominent role of the extracellular-transmembrane domain interface in allosteric modulation.

Authors:  Tommy S Tillman; Edom Seyoum; David D Mowrey; Yan Xu; Pei Tang
Journal:  J Biol Chem       Date:  2014-04-02       Impact factor: 5.157

Review 6.  Nicotinic Acetylcholine Receptor Ligands, Cognitive Function, and Preclinical Approaches to Drug Discovery.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

7.  Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice.

Authors:  Megan J Moerke; Fernando B de Moura; Wouter Koek; Lance R McMahon
Journal:  Eur J Pharmacol       Date:  2016-05-27       Impact factor: 4.432

8.  Levamisole: A Positive Allosteric Modulator for the α3β4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet.

Authors:  Jeanne A Lewis; Jerrel L Yakel; Anshul A Pandya
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

9.  Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.

Authors:  Jakob A Shimshoni; Ilan Winkler; Ezekiel Golan; David Nutt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-09-20       Impact factor: 3.000

10.  An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.

Authors:  Christopher B Marotta; Henry A Lester; Dennis A Dougherty
Journal:  Chem Biol       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.